Locations
Vancouver, BC, Canada
industry
Biotechnology · Health
Size
11-50 employees
Stage
Seed
founded in
2020
Proton Intelligence is pioneering the first real-time, on-demand potassium monitoring wearable, aimed at transforming the management of hyperkalemia, a condition affecting over 3.7 million Americans. The company focuses on providing clinicians with the tools to treat and manage kidney disease patients more safely and precisely, unlocking life-saving treatments that are currently limited by the inability to monitor potassium levels continuously. As a member of several prestigious accelerator programs, Proton Intelligence is positioned to disrupt the chronic kidney disease monitoring market, which has seen limited innovation compared to diabetes care. Their unique product addresses a significant gap in the healthcare market, offering a solution that could lead to better patient outcomes and reduced healthcare costs.
Something looks off?On-site & Remote